NASDAQ:HQY - Healthequity Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$68.38 -5.65 (-7.63 %)
(As of 12/10/2018 01:23 AM ET)
Previous Close$68.38
Today's Range$66.86 - $76.34
52-Week Range$42.92 - $101.58
Volume2.34 million shs
Average Volume784,904 shs
Market Capitalization$4.24 billion
P/E Ratio126.63
Dividend YieldN/A
Beta1.37
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.

Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HQY
Previous Symbol
CUSIPN/A
Phone801-727-1000

Debt

Debt-to-Equity RatioN/A
Current Ratio20.91
Quick Ratio19.90

Price-To-Earnings

Trailing P/E Ratio126.63
Forward P/E Ratio78.60
P/E Growth2.52

Sales & Book Value

Annual Sales$229.52 million
Price / Sales18.49
Cash Flow$0.8140 per share
Price / Cash Flow84.00
Book Value$7.36 per share
Price / Book9.29

Profitability

EPS (Most Recent Fiscal Year)$0.54
Net Income$47.36 million
Net Margins24.52%
Return on Equity12.42%
Return on Assets11.79%

Miscellaneous

Employees1,027
Outstanding Shares62,050,000
Market Cap$4.24 billion
OptionableOptionable

Healthequity (NASDAQ:HQY) Frequently Asked Questions

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) released its quarterly earnings results on Tuesday, December, 4th. The company reported $0.22 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.20 by $0.02. The firm earned $70.50 million during the quarter, compared to analysts' expectations of $69.60 million. Healthequity had a return on equity of 12.42% and a net margin of 24.52%. The business's revenue was up 24.1% on a year-over-year basis. During the same period last year, the firm posted $0.17 EPS. View Healthequity's Earnings History.

When is Healthequity's next earnings date?

Healthequity is scheduled to release their next quarterly earnings announcement on Monday, March 18th 2019. View Earnings Estimates for Healthequity.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity updated its FY19 earnings guidance on Tuesday, December, 4th. The company provided earnings per share (EPS) guidance of $1.03-1.09 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.05. The company issued revenue guidance of $281-285 million, compared to the consensus revenue estimate of $284.03 million.Healthequity also updated its FY 2019 guidance to $1.06-1.13 EPS.

What price target have analysts set for HQY?

12 analysts have issued 1 year price objectives for Healthequity's shares. Their predictions range from $69.00 to $110.00. On average, they expect Healthequity's share price to reach $92.8333 in the next twelve months. This suggests a possible upside of 35.8% from the stock's current price. View Analyst Price Targets for Healthequity.

What is the consensus analysts' recommendation for Healthequity?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.

What are Wall Street analysts saying about Healthequity stock?

Here are some recent quotes from research analysts about Healthequity stock:
  • 1. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on HQY shares and increase our price target to $82 from $80. After the market close on the company reported strong F3Q19 results that were ahead of our estimates and FactSet consensus. HQY raised its full year guidance ranges at their midpoints. We believe the company is poised for strong growth in F20. HQY’s 4Q is the company’s most active quarter for new member growth. The company also mentioned investments it will be making in 4Q and FY2020. The investments will be offset by a lower than expected tax rate. We maintain our view that the shares’ current valuation already reflects the company’s long-term growth potential." (12/6/2018)
  • 2. According to Zacks Investment Research, "HealthEquity outperformed the industry in a year’s time. The company saw strong HSA member growth recently. HealthEquity is currently the third-largest HSA custodian by market share. In addition to HSA, the company offers health reimbursement arrangement (HRA) and a health flexible spending account (FSA) to regional employers. Apart from this, HealthEquity’s 401(K) solution that lowers the cost, risk and work of managing a retirement plan buoys optimism. Management is optimistic about the launch of HealthEquity retirement services. However, it faces stiff competition in the Medical Services market. Surging operating expenses are another cause of concern. The company is required to comply with strict Treasury Regulations formulated by the Internal Revenue Service or the IRS. The stock also looks a bit overvalued." (11/20/2018)

Has Healthequity been receiving favorable news coverage?

Media stories about HQY stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Healthequity earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.

Who are some of Healthequity's key competitors?

Who are Healthequity's key executives?

Healthequity's management team includes the folowing people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 50)
  • Mr. Darcy G. Mott, Exec. VP & CFO (Age 65)
  • Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 45)
  • Mr. William Robert Otten, Exec. VP of Sales (Age 53)
  • Mr. Edward Bloomberg, Exec. VP & COO (Age 42)

Who are Healthequity's major shareholders?

Healthequity's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.73%), Vanguard Group Inc. (8.53%), Morgan Stanley (6.45%), FMR LLC (5.62%), Janus Henderson Group PLC (4.13%) and Wasatch Advisors Inc. (2.54%). Company insiders that own Healthequity stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan, Manu S Rana and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.

Which major investors are selling Healthequity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including Berkley W R Corp, BlackRock Inc., Wasatch Advisors Inc., Bamco Inc. NY, Amussen Hunsaker Associates LLC, Vanguard Group Inc., Franklin Resources Inc. and Wells Fargo & Company MN. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Insider Buying and Selling for Healthequity.

Which major investors are buying Healthequity stock?

HQY stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, Clearbridge Investments LLC, Mirae Asset Global Investments Co. Ltd., Pictet Asset Management Ltd., Bank of New York Mellon Corp, Renaissance Technologies LLC, First Quadrant L P CA and Retirement Systems of Alabama. View Insider Buying and Selling for Healthequity.

How do I buy shares of Healthequity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Healthequity's stock price today?

One share of HQY stock can currently be purchased for approximately $68.38.

How big of a company is Healthequity?

Healthequity has a market capitalization of $4.24 billion and generates $229.52 million in revenue each year. The company earns $47.36 million in net income (profit) each year or $0.54 on an earnings per share basis. Healthequity employs 1,027 workers across the globe.

What is Healthequity's official website?

The official website for Healthequity is http://www.healthequity.com.

How can I contact Healthequity?

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]


MarketBeat Community Rating for Healthequity (NASDAQ HQY)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  301 (Vote Outperform)
Underperform Votes:  239 (Vote Underperform)
Total Votes:  540
MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel